ONTOLOGY REPORT - ANNOTATIONS
| Term: | ammonium chloride |
|
| Accession: | CHEBI:31206
|
browse the term
|
| Definition: | An inorganic chloride salt that has formula ClH4N. |
| Synonyms: | related_synonym: | Ammoniumchlorid; Cl.H4N; ClH4N; InChI=1S/ClH.H3N/h1H;1H3; InChIKey=NLXLAEXVIDQMFP-UHFFFAOYSA-N; NH4Cl; [Cl-].[H][N+]([H])([H])[H]; [NH4]Cl |
| | xref_casrn: | 12125-02-9 |
| | xref: | ChEMBL:774890 "ChEMBL COMPOUND"; ChemIDplus:12125-02-9 "CAS Registry Number"; Gmelin:10120 "Gmelin Registry Number"; KEGG COMPOUND:12125-02-9 "CAS Registry Number"; KEGG COMPOUND:C12538 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D000643 |
| | xref: | NIST Chemistry WebBook:12125-02-9 "CAS Registry Number"; Wikipedia:Ammonium_Chloride "Wikipedia" |
|
|
ammonium chloride
|
| G |
A1bg |
alpha-1-B glycoprotein |
|
affects expression |
EXP |
7 |
97,799,125 |
97,802,842 |
RGD:6480464 |
CTD |
| G |
A1cf |
APOBEC1 complementation factor |
|
affects expression |
EXP |
1 |
235,865,843 |
235,958,065 |
RGD:6480464 |
CTD |
| G |
A2m |
alpha-2-macroglobulin |
|
affects expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
A4galt |
alpha 1,4-galactosyltransferase |
|
affects expression |
EXP |
7 |
121,252,117 |
121,255,671 |
RGD:6480464 |
CTD |
| G |
Aacs |
acetoacetyl-CoA synthetase |
|
affects expression |
EXP |
12 |
32,206,863 |
32,250,583 |
RGD:6480464 |
CTD |
| G |
Aadac |
arylacetamide deacetylase |
|
affects expression |
EXP |
2 |
149,348,935 |
149,360,181 |
RGD:6480464 |
CTD |
| G |
Aadat |
aminoadipate aminotransferase |
|
affects expression |
EXP |
16 |
32,845,006 |
32,885,600 |
RGD:6480464 |
CTD |
| G |
Aagab |
alpha- and gamma-adaptin binding protein |
|
affects expression |
EXP |
8 |
67,777,269 |
67,814,192 |
RGD:6480464 |
CTD |
| G |
Aanat |
aralkylamine N-acetyltransferase |
|
affects expression |
EXP |
10 |
106,709,371 |
106,713,683 |
RGD:6480464 |
CTD |
| G |
Aard |
alanine and arginine rich domain containing protein |
|
affects expression |
EXP |
7 |
88,346,189 |
88,351,030 |
RGD:6480464 |
CTD |
| G |
Aatf |
apoptosis antagonizing transcription factor |
|
affects expression |
EXP |
10 |
72,701,724 |
72,794,495 |
RGD:6480464 |
CTD |
| G |
Abat |
4-aminobutyrate aminotransferase |
|
affects expression |
EXP |
10 |
7,040,725 |
7,137,154 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
affects expression |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca5 |
ATP-binding cassette, subfamily A (ABC1), member 5 |
|
affects expression |
EXP |
10 |
99,724,778 |
99,793,593 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
affects expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
affects expression |
EXP |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb6 |
ATP-binding cassette, subfamily B (MDR/TAP), member 6 |
|
affects expression |
EXP |
9 |
74,454,805 |
74,463,083 |
RGD:6480464 |
CTD |
| G |
Abcb9 |
ATP-binding cassette, subfamily B (MDR/TAP), member 9 |
|
affects expression |
EXP |
12 |
33,623,383 |
33,656,242 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
affects expression |
EXP |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
affects expression |
EXP |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects expression |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
affects expression |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 9 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
affects expression |
EXP |
7 |
129,542,758 |
129,591,363 |
RGD:6480464 |
CTD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
affects expression |
EXP |
2 |
218,396,071 |
218,432,172 |
RGD:6480464 |
CTD |
| G |
Abcf1 |
ATP-binding cassette, subfamily F (GCN20), member 1 |
|
affects expression |
EXP |
20 |
2,953,604 |
2,962,140 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
affects expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
affects expression |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
affects expression |
EXP |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Abcg8 |
ATP-binding cassette, subfamily G (WHITE), member 8 |
|
affects expression |
EXP |
6 |
8,064,631 |
8,083,271 |
RGD:6480464 |
CTD |
| G |
Abi1 |
abl-interactor 1 |
|
affects expression |
EXP |
17 |
96,576,331 |
96,648,752 |
RGD:6480464 |
CTD |
| G |
Abi2 |
abl-interactor 2 |
|
affects expression |
EXP |
9 |
59,028,651 |
59,079,887 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression |
EXP |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abo |
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) |
|
affects expression |
EXP |
3 |
5,730,553 |
5,751,204 |
RGD:6480464 |
CTD |
| G |
Abo2 |
histo-blood group ABO system transferase 2 |
|
affects expression |
EXP |
3 |
5,589,306 |
5,596,367 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
affects expression |
EXP |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Abra |
actin-binding Rho activating protein |
|
affects expression |
EXP |
7 |
77,506,885 |
77,510,953 |
RGD:6480464 |
CTD |
| G |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
|
affects expression |
EXP |
3 |
88,858,336 |
89,012,166 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
affects expression |
EXP |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
affects expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
affects expression |
EXP |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
affects expression |
EXP |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
affects expression |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
affects expression |
EXP |
12 |
42,765,284 |
42,774,528 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
affects expression |
EXP |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
affects expression |
EXP |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
affects expression |
EXP |
8 |
57,044,478 |
57,072,970 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
affects expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
affects expression |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
affects expression |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
affects expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
affects expression |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot12 |
acyl-CoA thioesterase 12 |
|
affects expression |
EXP |
2 |
21,984,849 |
22,035,224 |
RGD:6480464 |
CTD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
affects expression |
EXP |
6 |
108,017,574 |
108,024,387 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
affects expression |
EXP |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
affects expression |
EXP |
5 |
169,409,306 |
169,501,907 |
RGD:6480464 |
CTD |
| G |
Acot8 |
acyl-CoA thioesterase 8 |
|
affects expression |
EXP |
3 |
155,828,209 |
155,839,862 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
affects expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
affects expression |
EXP |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
affects expression |
EXP |
14 |
80,769,000 |
80,809,809 |
RGD:6480464 |
CTD |
| G |
Acp2 |
acid phosphatase 2, lysosomal |
|
affects expression |
EXP |
3 |
75,559,522 |
75,568,415 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
affects expression |
EXP |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Acrv1 |
acrosomal vesicle protein 1 |
|
affects expression |
EXP |
8 |
37,938,151 |
37,943,728 |
RGD:6480464 |
CTD |
| G |
Acsbg1 |
acyl-CoA synthetase bubblegum family member 1 |
|
affects expression |
EXP |
8 |
58,156,231 |
58,212,485 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
affects expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
affects expression |
EXP |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
affects expression |
EXP |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
affects expression |
EXP |
10 |
39,729,805 |
39,778,106 |
RGD:6480464 |
CTD |
| G |
Acsm2a |
acyl-CoA synthetase medium-chain family member 2A |
|
affects expression |
EXP |
1 |
177,830,613 |
177,869,061 |
RGD:6480464 |
CTD |
| G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
|
affects expression |
EXP |
1 |
178,054,386 |
178,081,751 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
affects expression |
EXP |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
affects expression |
EXP |
6 |
103,188,593 |
103,282,873 |
RGD:6480464 |
CTD |
| G |
Actn3 |
actinin alpha 3 |
|
affects expression |
EXP |
1 |
207,475,569 |
207,492,267 |
RGD:6480464 |
CTD |
| G |
Actn4 |
actinin alpha 4 |
|
affects expression |
EXP |
1 |
84,000,723 |
84,073,767 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 homolog (yeast) |
|
affects expression |
EXP |
13 |
37,861,558 |
37,904,589 |
RGD:6480464 |
CTD |
| G |
Acvr1b |
activin A receptor, type IB |
|
affects expression |
EXP |
7 |
139,910,157 |
139,958,740 |
RGD:6480464 |
CTD |
| G |
Acvr1c |
activin A receptor, type IC |
|
affects expression |
EXP |
3 |
40,027,228 |
40,102,303 |
RGD:6480464 |
CTD |
| G |
Acvr2a |
activin A receptor, type IIA |
|
affects expression |
EXP |
3 |
29,779,827 |
29,808,881 |
RGD:6480464 |
CTD |
| G |
Acvr2b |
activin A receptor, type IIB |
|
affects expression |
EXP |
8 |
124,364,330 |
124,395,748 |
RGD:6480464 |
CTD |
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
affects expression |
EXP |
7 |
139,873,596 |
139,884,675 |
RGD:6480464 |
CTD |
| G |
Ada |
adenosine deaminase |
|
affects expression |
EXP |
3 |
154,636,530 |
154,660,637 |
RGD:6480464 |
CTD |
| G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
affects expression |
EXP |
8 |
75,200,657 |
75,289,572 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
affects expression |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
affects expression |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adam18 |
ADAM metallopeptidase domain 18 |
|
affects expression |
EXP |
16 |
71,782,433 |
71,860,913 |
RGD:6480464 |
CTD |
| G |
Afap1 |
actin filament associated protein 1 |
|
affects expression |
EXP |
14 |
80,355,358 |
80,448,224 |
RGD:6480464 |
CTD |
| G |
Afm |
afamin |
|
affects expression |
EXP |
14 |
19,049,664 |
19,082,977 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
affects expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
|
affects expression |
EXP |
7 |
67,031,300 |
67,043,909 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
affects expression |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
|
affects expression |
EXP |
1 |
42,986,809 |
43,096,390 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
affects expression |
EXP |
5 |
172,999,420 |
173,020,764 |
RGD:6480464 |
CTD |
| G |
Agrp |
agouti related protein homolog (mouse) |
|
affects expression |
EXP |
19 |
35,386,682 |
35,388,274 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
affects expression |
EXP |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agxt |
alanine-glyoxylate aminotransferase |
|
affects expression |
EXP |
9 |
92,412,128 |
92,422,075 |
RGD:6480464 |
CTD |
| G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
|
affects expression |
EXP |
2 |
59,713,365 |
59,754,876 |
RGD:6480464 |
CTD |
| G |
Ahcy |
adenosylhomocysteinase |
|
affects expression |
EXP |
3 |
145,544,834 |
145,560,058 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
affects expression |
EXP |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
affects expression |
EXP |
11 |
80,330,615 |
80,336,658 |
RGD:6480464 |
CTD |
| G |
Aif1 |
allograft inflammatory factor 1 |
|
affects expression |
EXP |
20 |
3,714,428 |
3,716,327 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects expression |
EXP |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
affects expression |
EXP |
2 |
230,142,679 |
230,166,226 |
RGD:6480464 |
CTD |
| G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
|
affects expression |
EXP |
1 |
206,697,248 |
206,704,457 |
RGD:6480464 |
CTD |
| G |
Aipl1 |
aryl hydrocarbon receptor-interacting protein-like 1 |
|
affects expression |
EXP |
10 |
58,879,846 |
58,913,985 |
RGD:6480464 |
CTD |
| G |
Ak1 |
adenylate kinase 1 |
|
affects expression |
EXP |
2 |
19,821,482 |
19,822,544 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
affects expression |
EXP |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Ak3 |
adenylate kinase 3 |
|
affects expression |
EXP |
1 |
232,658,879 |
232,684,083 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
affects expression |
EXP |
5 |
122,062,872 |
122,119,335 |
RGD:6480464 |
CTD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
affects expression |
EXP |
10 |
77,262,592 |
77,276,832 |
RGD:6480464 |
CTD |
| G |
Akap11 |
A kinase (PRKA) anchor protein 11 |
|
affects expression |
EXP |
15 |
59,649,461 |
59,679,551 |
RGD:6480464 |
CTD |
| G |
Akap14 |
A kinase (PRKA) anchor protein 14 |
|
affects expression |
EXP |
X |
7,744,305 |
7,759,380 |
RGD:6480464 |
CTD |
| G |
Akap4 |
A kinase (PRKA) anchor protein 4 |
|
affects expression |
EXP |
X |
27,515,009 |
27,524,606 |
RGD:6480464 |
CTD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
affects expression |
EXP |
6 |
98,923,105 |
98,928,505 |
RGD:6480464 |
CTD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
affects expression |
EXP |
6 |
73,010,779 |
73,354,520 |
RGD:6480464 |
CTD |
| G |
Akap8 |
A kinase (PRKA) anchor protein 8 |
|
affects expression |
EXP |
7 |
12,873,303 |
12,889,333 |
RGD:6480464 |
CTD |
| G |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
|
affects expression |
EXP |
4 |
26,772,929 |
26,803,149 |
RGD:6480464 |
CTD |
| G |
Akp3 |
alkaline phosphatase 3, intestine, not Mn requiring |
|
affects expression |
EXP |
9 |
85,924,232 |
85,927,327 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
affects expression |
EXP |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
affects expression |
EXP |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1b1-ps2 |
aldo-keto reductase family 1, member B1 (aldose reductase), pseudogene 2 |
|
affects expression |
EXP |
4 |
153,167,722 |
153,168,672 |
RGD:6480464 |
CTD |
| G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
|
affects expression |
EXP |
4 |
61,794,352 |
61,806,916 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
affects expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1c14 |
aldo-keto reductase family 1, member C14 |
|
affects expression |
EXP |
17 |
77,316,456 |
77,332,903 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
affects expression |
EXP |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
affects expression |
EXP |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Akr7a2 |
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
|
affects expression |
EXP |
5 |
158,097,679 |
158,106,217 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt3 |
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
|
affects expression |
EXP |
13 |
92,802,390 |
93,110,704 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
affects expression |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
affects expression |
EXP |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh16a1 |
aldehyde dehydrogenase 16 family, member A1 |
|
affects expression |
EXP |
1 |
95,617,726 |
95,630,798 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
affects expression |
EXP |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
affects expression |
EXP |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects expression |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
affects expression |
EXP |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
affects expression |
EXP |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
|
affects expression |
EXP |
17 |
47,193,407 |
47,216,499 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
|
affects expression |
EXP |
6 |
108,495,781 |
108,516,414 |
RGD:6480464 |
CTD |
| G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
|
affects expression |
EXP |
18 |
52,300,899 |
52,333,149 |
RGD:6480464 |
CTD |
| G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
affects expression |
EXP |
13 |
83,017,312 |
83,034,047 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
affects expression |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
affects expression |
EXP |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
affects expression |
EXP |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
affects expression |
EXP |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Allc |
allantoicase |
|
affects expression |
EXP |
6 |
46,421,144 |
46,456,709 |
RGD:6480464 |
CTD |
| G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
|
affects expression |
EXP |
10 |
55,951,005 |
55,960,265 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
affects expression |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
affects expression |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alpi |
alkaline phosphatase, intestinal |
|
affects expression |
EXP |
9 |
85,892,887 |
85,896,353 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
affects expression |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alx1 |
ALX homeobox 1 |
|
affects expression |
EXP |
7 |
41,090,481 |
41,110,281 |
RGD:6480464 |
CTD |
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
affects expression |
EXP |
2 |
60,332,292 |
60,344,326 |
RGD:6480464 |
CTD |
| G |
Ambn |
ameloblastin |
|
affects expression |
EXP |
14 |
21,183,338 |
21,196,650 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
affects expression |
EXP |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Ambra1 |
autophagy/beclin 1 regulator 1 |
|
affects expression |
EXP |
3 |
76,109,632 |
76,298,784 |
RGD:6480464 |
CTD |
| G |
Amd1 |
adenosylmethionine decarboxylase 1 |
|
affects expression |
EXP |
20 |
44,452,475 |
44,468,111 |
RGD:6480464 |
CTD |
| G |
Amelx |
amelogenin, X-linked |
|
affects expression |
EXP |
X |
45,763,451 |
45,769,374 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
affects expression |
EXP |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Amhr2 |
anti-Mullerian hormone receptor, type II |
|
affects expression |
EXP |
7 |
141,203,832 |
141,212,653 |
RGD:6480464 |
CTD |
| G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
|
affects expression |
EXP |
2 |
203,752,632 |
203,754,113 |
RGD:6480464 |
CTD |
| G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
|
affects expression |
EXP |
7 |
135,966,794 |
135,969,747 |
RGD:6480464 |
CTD |
| G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
|
affects expression |
EXP |
8 |
113,321,258 |
113,322,784 |
RGD:6480464 |
CTD |
| G |
Amotl2 |
angiomotin like 2 |
|
affects expression |
EXP |
8 |
107,694,405 |
107,709,841 |
RGD:6480464 |
CTD |
| G |
Ampd1 |
adenosine monophosphate deaminase 1 |
|
affects expression |
EXP |
2 |
198,308,512 |
198,331,019 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
affects expression |
EXP |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Amph |
amphiphysin |
|
affects expression |
EXP |
17 |
53,558,804 |
53,802,936 |
RGD:6480464 |
CTD |
| G |
Amy1a |
amylase, alpha 1A (salivary) |
|
affects expression |
EXP |
2 |
209,548,721 |
209,563,532 |
RGD:6480464 |
CTD |
| G |
Andpro |
androgen regulated protein |
|
affects expression |
EXP |
3 |
138,085,660 |
138,092,024 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
affects expression |
EXP |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
affects expression |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
affects expression |
EXP |
3 |
12,226,515 |
12,256,396 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
affects expression |
EXP |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ank3 |
ankyrin 3, node of Ranvier (ankyrin G) |
|
affects expression |
EXP |
20 |
19,328,684 |
19,828,196 |
RGD:6480464 |
CTD |
| G |
Aqp11 |
aquaporin 11 |
|
affects expression |
EXP |
1 |
154,973,796 |
154,983,962 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
affects expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
affects expression |
EXP |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
affects expression |
EXP |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
increases expression |
EXP |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Aqp5 |
aquaporin 5 |
|
affects expression |
EXP |
7 |
138,337,725 |
138,341,257 |
RGD:6480464 |
CTD |
| G |
Aqp6 |
aquaporin 6, kidney specific |
|
affects expression |
EXP |
7 |
138,347,266 |
138,350,199 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
affects expression |
EXP |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Aqp8 |
aquaporin 8 |
|
affects expression |
EXP |
1 |
182,331,494 |
182,337,291 |
RGD:6480464 |
CTD |
| G |
Aqp9 |
aquaporin 9 |
|
affects expression |
EXP |
8 |
75,611,485 |
75,651,646 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
affects expression |
EXP |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
affects expression |
EXP |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
affects expression |
EXP |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arf4 |
ADP-ribosylation factor 4 |
|
affects expression |
EXP |
16 |
1,955,745 |
1,972,321 |
RGD:6480464 |
CTD |
| G |
Arf5 |
ADP-ribosylation factor 5 |
|
affects expression |
EXP |
4 |
55,293,825 |
55,296,751 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
affects expression |
EXP |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arfgap1 |
ADP-ribosylation factor GTPase activating protein 1 |
|
affects expression |
EXP |
3 |
170,075,313 |
170,100,744 |
RGD:6480464 |
CTD |
| G |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
|
affects expression |
EXP |
2 |
176,275,425 |
176,353,675 |
RGD:6480464 |
CTD |
| G |
Arfrp1 |
ADP-ribosylation factor related protein 1 |
|
affects expression |
EXP |
3 |
170,499,593 |
170,505,513 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects expression |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
affects expression |
EXP |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arhgap17 |
Rho GTPase activating protein 17 |
|
affects expression |
EXP |
1 |
182,145,313 |
182,234,995 |
RGD:6480464 |
CTD |
| G |
Arhgap39 |
Rho GTPase activating protein 39 |
|
affects expression |
EXP |
7 |
114,776,991 |
114,866,861 |
RGD:6480464 |
CTD |
| G |
Arhgap4 |
Rho GTPase activating protein 4 |
|
affects expression |
EXP |
X |
159,824,136 |
159,839,008 |
RGD:6480464 |
CTD |
| G |
Arhgef1 |
Rho guanine nucleotide exchange factor (GEF) 1 |
|
affects expression |
EXP |
1 |
80,209,459 |
80,226,353 |
RGD:6480464 |
CTD |
| G |
Arhgef11 |
Rho guanine nucleotide exchange factor (GEF) 11 |
|
affects expression |
EXP |
2 |
179,676,236 |
179,796,785 |
RGD:6480464 |
CTD |
| G |
Arhgef5 |
Rho guanine nucleotide exchange factor (GEF) 5 |
|
affects expression |
EXP |
4 |
71,036,550 |
71,053,522 |
RGD:6480464 |
CTD |
| G |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
|
affects expression |
EXP |
16 |
82,521,224 |
82,603,338 |
RGD:6480464 |
CTD |
| G |
Arid1b |
AT rich interactive domain 1B (Swi1 like) |
|
affects expression |
EXP |
1 |
40,012,872 |
40,324,266 |
RGD:6480464 |
CTD |
| G |
Arid4b |
AT rich interactive domain 4B (Rbp1 like) |
|
affects expression |
EXP |
17 |
59,334,046 |
59,457,079 |
RGD:6480464 |
CTD |
| G |
Arl1 |
ADP-ribosylation factor-like 1 |
|
affects expression |
EXP |
7 |
25,403,921 |
25,416,168 |
RGD:6480464 |
CTD |
| G |
Arl2 |
ADP-ribosylation factor-like 2 |
|
affects expression |
EXP |
1 |
208,909,458 |
208,921,401 |
RGD:6480464 |
CTD |
| G |
Arl3 |
ADP-ribosylation factor-like 3 |
|
affects expression |
EXP |
1 |
251,756,117 |
251,870,843 |
RGD:6480464 |
CTD |
| G |
Arl4a |
ADP-ribosylation factor-like 4A |
|
affects expression |
EXP |
6 |
59,212,599 |
59,214,609 |
RGD:6480464 |
CTD |
| G |
Arl5a |
ADP-ribosylation factor-like 5A |
|
affects expression |
EXP |
3 |
33,905,755 |
33,926,681 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
affects expression |
EXP |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
affects expression |
EXP |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
affects expression |
EXP |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
affects expression |
EXP |
12 |
9,796,269 |
9,803,639 |
RGD:6480464 |
CTD |
| G |
Arr3 |
arrestin 3, retinal (X-arrestin) |
|
affects expression |
EXP |
X |
88,602,380 |
88,614,721 |
RGD:6480464 |
CTD |
| G |
Arrb1 |
arrestin, beta 1 |
|
affects expression |
EXP |
1 |
156,871,564 |
156,937,540 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
affects expression |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Arsb |
arylsulfatase B |
|
affects expression |
EXP |
2 |
24,067,560 |
24,223,821 |
RGD:6480464 |
CTD |
| G |
Art2b |
ADP-ribosyltransferase 2b |
|
affects expression |
EXP |
1 |
159,055,461 |
159,058,780 |
RGD:6480464 |
CTD |
| G |
Art3 |
ADP-ribosyltransferase 3 |
|
affects expression |
EXP |
14 |
17,198,267 |
17,280,642 |
RGD:6480464 |
CTD |
| G |
Art5 |
ADP-ribosyltransferase 5 |
|
affects expression |
EXP |
1 |
159,576,990 |
159,586,949 |
RGD:6480464 |
CTD |
| G |
Artn |
artemin |
|
affects expression |
EXP |
5 |
138,390,981 |
138,394,250 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects expression |
EXP |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
affects expression |
EXP |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
affects expression |
EXP |
1 |
236,000,768 |
236,072,477 |
RGD:6480464 |
CTD |
| G |
Ascl1 |
achaete-scute complex homolog 1 (Drosophila) |
|
affects expression |
EXP |
7 |
24,145,578 |
24,168,494 |
RGD:6480464 |
CTD |
| G |
Ascl2 |
achaete-scute complex homolog 2 (Drosophila) |
|
affects expression |
EXP |
1 |
203,242,130 |
203,244,480 |
RGD:6480464 |
CTD |
| G |
Ascl3 |
achaete-scute complex homolog 3 (Drosophila) |
|
affects expression |
EXP |
1 |
167,345,397 |
167,349,614 |
RGD:6480464 |
CTD |
| G |
Asgr1 |
asialoglycoprotein receptor 1 |
|
affects expression |
EXP |
10 |
56,899,266 |
56,903,173 |
RGD:6480464 |
CTD |
| G |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
|
affects expression |
EXP |
7 |
138,414,656 |
138,443,272 |
RGD:6480464 |
CTD |
| G |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
|
affects expression |
EXP |
10 |
69,103,244 |
70,190,305 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
affects expression |
EXP |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Asic4 |
acid-sensing (proton-gated) ion channel family member 4 |
|
affects expression |
EXP |
9 |
74,728,291 |
74,749,661 |
RGD:6480464 |
CTD |
| G |
Asic5 |
acid-sensing (proton-gated) ion channel family member 5 |
|
affects expression |
EXP |
2 |
173,632,309 |
173,662,245 |
RGD:6480464 |
CTD |
| G |
Asip |
agouti signaling protein |
|
affects expression |
EXP |
3 |
145,445,175 |
145,536,831 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
affects expression |
EXP |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Asmt |
acetylserotonin O-methyltransferase |
|
affects expression |
EXP |
12 |
16,811,892 |
16,817,186 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
affects expression |
EXP |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Aspa |
aspartoacylase |
|
affects expression |
EXP |
10 |
60,178,509 |
60,199,207 |
RGD:6480464 |
CTD |
| G |
Aspg |
asparaginase homolog (S. cerevisiae) |
|
affects expression |
EXP |
6 |
136,909,407 |
136,928,801 |
RGD:6480464 |
CTD |
| G |
Asrgl1 |
asparaginase like 1 |
|
affects expression |
EXP |
1 |
211,788,145 |
211,808,943 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
affects expression |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Asz1 |
ankyrin repeat, SAM and basic leucine zipper domain containing 1 |
|
affects expression |
EXP |
4 |
43,715,678 |
43,771,281 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
affects expression |
EXP |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases expression |
EXP |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
affects expression |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
affects expression |
EXP |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
affects expression |
EXP |
11 |
57,162,205 |
57,190,568 |
RGD:6480464 |
CTD |
| G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
affects expression |
EXP |
9 |
70,676,744 |
70,696,865 |
RGD:6480464 |
CTD |
| G |
Atn1 |
atrophin 1 |
|
affects expression |
EXP |
4 |
160,872,360 |
160,886,205 |
RGD:6480464 |
CTD |
| G |
Atox1 |
ATX1 antioxidant protein 1 homolog (yeast) |
|
affects expression |
EXP |
10 |
40,858,190 |
40,873,226 |
RGD:6480464 |
CTD |
| G |
Atp11a |
ATPase, class VI, type 11A |
|
affects expression |
EXP |
16 |
81,514,979 |
81,624,861 |
RGD:6480464 |
CTD |
| G |
Atp12a |
ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
|
affects expression |
EXP |
15 |
35,295,274 |
35,321,453 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
affects expression |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a4 |
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
|
affects expression |
EXP |
13 |
88,213,848 |
88,249,075 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
affects expression |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
affects expression |
EXP |
10 |
56,418,323 |
56,424,465 |
RGD:6480464 |
CTD |
| G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
affects expression |
EXP |
8 |
101,405,877 |
101,437,757 |
RGD:6480464 |
CTD |
| G |
Atp1b4 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
|
affects expression |
EXP |
X |
7,025,531 |
7,046,207 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects expression |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a3 |
ATPase, Ca++ transporting, ubiquitous |
|
affects expression |
EXP |
10 |
59,853,363 |
59,884,087 |
RGD:6480464 |
CTD |
| G |
Atp2c1 |
ATPase, Ca++ transporting, type 2C, member 1 |
|
affects expression |
EXP |
8 |
110,516,092 |
110,603,620 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
affects expression |
EXP |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
affects expression |
EXP |
7 |
67,120,782 |
67,127,697 |
RGD:6480464 |
CTD |
| G |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
affects expression |
EXP |
5 |
58,196,388 |
58,243,231 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
affects expression |
EXP |
18 |
12,421,062 |
12,478,276 |
RGD:6480464 |
CTD |
| G |
Baat |
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
affects expression |
EXP |
5 |
66,245,786 |
66,254,757 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
affects expression |
EXP |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
affects expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag6 |
BCL2-associated athanogene 6 |
|
affects expression |
EXP |
20 |
3,739,593 |
3,752,311 |
RGD:6480464 |
CTD |
| G |
Baiap2 |
BAI1-associated protein 2 |
|
affects expression |
EXP |
10 |
109,351,201 |
109,413,703 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
affects expression |
EXP |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bambi |
BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) |
|
affects expression |
EXP |
17 |
62,654,385 |
62,658,641 |
RGD:6480464 |
CTD |
| G |
Banf1 |
barrier to autointegration factor 1 |
|
affects expression |
EXP |
1 |
208,008,344 |
208,010,342 |
RGD:6480464 |
CTD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
affects expression |
EXP |
9 |
70,120,151 |
70,198,591 |
RGD:6480464 |
CTD |
| G |
Barhl1 |
BarH-like homeobox 1 |
|
affects expression |
EXP |
3 |
7,917,842 |
7,925,164 |
RGD:6480464 |
CTD |
| G |
Barhl2 |
BarH-like homeobox 2 |
|
affects expression |
EXP |
14 |
3,888,153 |
3,893,050 |
RGD:6480464 |
CTD |
| G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
affects expression |
EXP |
2 |
76,877,616 |
76,927,721 |
RGD:6480464 |
CTD |
| G |
Batf3 |
basic leucine zipper transcription factor, ATF-like 3 |
|
affects expression |
EXP |
13 |
107,128,770 |
107,140,194 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
|
affects expression |
EXP |
3 |
95,747,735 |
95,786,852 |
RGD:6480464 |
CTD |
| G |
Bbs2 |
Bardet-Biedl syndrome 2 |
|
affects expression |
EXP |
19 |
11,347,432 |
11,382,830 |
RGD:6480464 |
CTD |
| G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
|
affects expression |
EXP |
1 |
79,067,352 |
79,081,739 |
RGD:6480464 |
CTD |
| G |
Bcan |
brevican |
|
affects expression |
EXP |
2 |
180,067,864 |
180,080,942 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
affects expression |
EXP |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bcas1 |
breast carcinoma amplified sequence 1 |
|
affects expression |
EXP |
3 |
161,395,062 |
161,475,655 |
RGD:6480464 |
CTD |
| G |
Bcat1 |
branched chain amino acid transaminase 1, cytosolic |
|
affects expression |
EXP |
4 |
182,641,517 |
182,692,917 |
RGD:6480464 |
CTD |
| G |
Bcat2 |
branched chain amino acid transaminase 2, mitochondrial |
|
affects expression |
EXP |
1 |
96,038,287 |
96,055,622 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
affects expression |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bckdha |
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
|
affects expression |
EXP |
1 |
80,837,906 |
80,866,672 |
RGD:6480464 |
CTD |
| G |
Bckdhb |
branched chain keto acid dehydrogenase E1, beta polypeptide |
|
affects expression |
EXP |
8 |
88,997,979 |
89,191,017 |
RGD:6480464 |
CTD |
| G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
affects expression |
EXP |
1 |
187,189,665 |
187,194,336 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
EXP |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
affects expression |
EXP |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l10 |
BCL2-like 10 (apoptosis facilitator) |
|
affects expression |
EXP |
8 |
80,172,804 |
80,178,851 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
affects expression |
EXP |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
Bcl2-like 2 |
|
affects expression |
EXP |
15 |
32,983,165 |
32,988,018 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
affects expression |
EXP |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
affects expression |
EXP |
11 |
71,130,561 |
71,165,695 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
affects expression |
EXP |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
affects expression |
EXP |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Begain |
brain-enriched guanylate kinase-associated |
|
affects expression |
EXP |
6 |
133,296,175 |
133,317,921 |
RGD:6480464 |
CTD |
| G |
Bet1 |
Bet1 golgi vesicular membrane trafficking protein |
|
affects expression |
EXP |
4 |
28,941,105 |
28,951,375 |
RGD:6480464 |
CTD |
| G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
|
affects expression |
EXP |
1 |
201,010,734 |
201,013,527 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
affects expression |
EXP |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
affects expression |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bhlha15 |
basic helix-loop-helix family, member a15 |
|
affects expression |
EXP |
12 |
10,747,865 |
10,752,041 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
affects expression |
EXP |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
affects expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
affects expression |
EXP |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer (apoptosis-inducing) |
|
affects expression |
EXP |
7 |
121,377,004 |
121,396,609 |
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
affects expression |
EXP |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
affects expression |
EXP |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
affects expression |
EXP |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Blcap |
bladder cancer associated protein |
|
affects expression |
EXP |
3 |
148,265,615 |
148,275,959 |
RGD:6480464 |
CTD |
| G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
|
affects expression |
EXP |
1 |
208,070,686 |
208,072,940 |
RGD:6480464 |
CTD |
| G |
Blmh |
bleomycin hydrolase |
|
affects expression |
EXP |
10 |
67,195,276 |
67,238,359 |
RGD:6480464 |
CTD |
| G |
Blvra |
biliverdin reductase A |
|
affects expression |
EXP |
3 |
114,627,972 |
114,645,004 |
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
affects expression |
EXP |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
affects expression |
EXP |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp15 |
bone morphogenetic protein 15 |
|
affects expression |
EXP |
X |
29,003,933 |
29,008,996 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
affects expression |
EXP |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp3 |
bone morphogenetic protein 3 |
|
affects expression |
EXP |
14 |
12,065,635 |
12,090,295 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
affects expression |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
affects expression |
EXP |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
affects expression |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type IA |
|
affects expression |
EXP |
16 |
10,061,943 |
10,105,854 |
RGD:6480464 |
CTD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
affects expression |
EXP |
9 |
58,327,587 |
58,436,057 |
RGD:6480464 |
CTD |
| G |
Bmyc |
brain expressed myelocytomatosis oncogene |
|
affects expression |
EXP |
3 |
3,864,740 |
3,865,499 |
RGD:6480464 |
CTD |
| G |
Bnip1 |
BCL2/adenovirus E1B interacting protein 1 |
|
affects expression |
EXP |
10 |
16,648,619 |
16,660,896 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects expression |
EXP |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
affects expression |
EXP |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer |
|
affects expression |
EXP |
9 |
92,970,069 |
92,980,974 |
RGD:6480464 |
CTD |
| G |
Bpifa1 |
BPI fold containing family A, member 1 |
|
affects expression |
EXP |
3 |
144,529,855 |
144,535,598 |
RGD:6480464 |
CTD |
| G |
Bpifa2 |
BPI fold containing family A, member 2 |
|
affects expression |
EXP |
3 |
144,395,541 |
144,403,499 |
RGD:6480464 |
CTD |
| G |
Bpifa2f |
BPI fold containing family A, member 2F |
|
affects expression |
EXP |
3 |
144,423,417 |
144,435,625 |
RGD:6480464 |
CTD |
| G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
affects expression |
EXP |
13 |
101,340,544 |
101,367,549 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
affects expression |
EXP |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
affects expression |
EXP |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brs3 |
bombesin-like receptor 3 |
|
affects expression |
EXP |
X |
141,688,650 |
141,693,028 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
affects expression |
EXP |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
affects expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
affects expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calcb |
calcitonin-related polypeptide, beta |
|
affects expression |
EXP |
1 |
172,777,347 |
172,781,003 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
affects expression |
EXP |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
affects expression |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
decreases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
affects expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
affects expression |
EXP |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Caly |
calcyon neuron-specific vesicular protein |
|
affects expression |
EXP |
1 |
199,869,223 |
199,880,102 |
RGD:6480464 |
CTD |
| G |
Camk1 |
calcium/calmodulin-dependent protein kinase I |
|
affects expression |
EXP |
4 |
149,220,661 |
149,229,168 |
RGD:6480464 |
CTD |
| G |
Camk1g |
calcium/calmodulin-dependent protein kinase IG |
|
affects expression |
EXP |
13 |
109,192,833 |
109,216,471 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
affects expression |
EXP |
18 |
56,879,247 |
56,948,537 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
affects expression |
EXP |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
affects expression |
EXP |
15 |
3,729,433 |
3,786,060 |
RGD:6480464 |
CTD |
| G |
Camk2n2 |
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
|
affects expression |
EXP |
11 |
82,519,331 |
82,519,584 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
affects expression |
EXP |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
decreases expression |
EXP |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Camkv |
CaM kinase-like vesicle-associated |
|
affects expression |
EXP |
8 |
113,205,817 |
113,220,164 |
RGD:6480464 |
CTD |
| G |
Camlg |
calcium modulating ligand |
|
affects expression |
EXP |
17 |
15,033,873 |
15,044,699 |
RGD:6480464 |
CTD |
| G |
Cand1 |
cullin-associated and neddylation-dissociated 1 |
|
affects expression |
EXP |
7 |
58,461,205 |
58,499,092 |
RGD:6480464 |
CTD |
| G |
Cand2 |
cullin-associated and neddylation-dissociated 2 (putative) |
|
affects expression |
EXP |
4 |
151,912,174 |
151,940,734 |
RGD:6480464 |
CTD |
| G |
Cant1 |
calcium activated nucleotidase 1 |
|
affects expression |
EXP |
10 |
108,405,355 |
108,420,225 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
affects expression |
EXP |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
decreases expression |
EXP |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Cap1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
|
affects expression |
EXP |
5 |
142,174,441 |
142,201,120 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
affects expression |
EXP |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn3 |
calpain 3 |
|
affects expression |
EXP |
3 |
106,946,878 |
106,998,274 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
affects expression |
EXP |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Capn6 |
calpain 6 |
|
affects expression |
EXP |
X |
34,697,658 |
34,722,369 |
RGD:6480464 |
CTD |
| G |
Capn8 |
calpain 8 |
|
affects expression |
EXP |
13 |
98,577,291 |
98,663,533 |
RGD:6480464 |
CTD |
| G |
Capn9 |
calpain 9 |
|
affects expression |
EXP |
19 |
54,759,009 |
54,796,390 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
affects expression |
EXP |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Capza3 |
capping protein (actin filament) muscle Z-line, alpha 3 |
|
affects expression |
EXP |
4 |
177,163,025 |
177,164,238 |
RGD:6480464 |
CTD |
| G |
Car11 |
carbonic anhydrase 11 |
|
affects expression |
EXP |
1 |
96,167,823 |
96,172,934 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
affects expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
affects expression |
EXP |
10 |
73,229,211 |
73,237,707 |
RGD:6480464 |
CTD |
| G |
Car5a |
carbonic anhydrase 5a, mitochondrial |
|
affects expression |
EXP |
19 |
52,158,607 |
52,188,664 |
RGD:6480464 |
CTD |
| G |
Card9 |
caspase recruitment domain family, member 9 |
|
affects expression |
EXP |
3 |
4,524,781 |
4,533,412 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
affects expression |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Casc3 |
cancer susceptibility candidate 3 |
|
affects expression |
EXP |
10 |
87,581,850 |
87,602,528 |
RGD:6480464 |
CTD |
| G |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
affects expression |
EXP |
X |
20,910,960 |
21,250,869 |
RGD:6480464 |
CTD |
| G |
Caskin1 |
CASK interacting protein 1 |
|
affects expression |
EXP |
10 |
13,740,593 |
13,760,485 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
increases activity |
EXP |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
affects expression |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
increases expression |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
increases activity |
EXP |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
affects expression |
EXP |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
affects expression |
EXP |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases expression |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
affects expression |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
affects expression |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases expression |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
affects expression |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
affects expression |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casq2 |
calsequestrin 2 (cardiac muscle) |
|
affects expression |
EXP |
2 |
197,182,938 |
197,239,201 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
affects expression |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
affects expression |
EXP |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
affects expression |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav2 |
caveolin 2 |
|
affects expression |
EXP |
4 |
42,932,127 |
42,939,503 |
RGD:6480464 |
CTD |
| G |
Cav3 |
caveolin 3 |
|
affects expression |
EXP |
4 |
148,294,428 |
148,310,380 |
RGD:6480464 |
CTD |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
affects expression |
EXP |
11 |
49,690,402 |
49,856,762 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
affects expression |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cbwd1 |
COBW domain containing 1 |
|
affects expression |
EXP |
1 |
228,360,614 |
228,402,151 |
RGD:6480464 |
CTD |
| G |
Cby1 |
chibby homolog 1 (Drosophila) |
|
affects expression |
EXP |
7 |
117,903,217 |
117,908,964 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
affects expression |
EXP |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccbp2 |
chemokine binding protein 2 |
|
affects expression |
EXP |
8 |
127,026,528 |
127,028,214 |
RGD:6480464 |
CTD |
| G |
Ccdc50 |
coiled-coil domain containing 50 |
|
affects expression |
EXP |
11 |
75,302,647 |
75,360,549 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
affects expression |
EXP |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Cckar |
cholecystokinin A receptor |
|
affects expression |
EXP |
14 |
62,052,510 |
62,057,201 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
affects expression |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
affects expression |
EXP |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
affects expression |
EXP |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
affects expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
affects expression |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
affects expression |
EXP |
19 |
10,697,324 |
10,704,129 |
RGD:6480464 |
CTD |
| G |
Ccl24 |
chemokine (C-C motif) ligand 24 |
|
affects expression |
EXP |
12 |
22,255,293 |
22,259,290 |
RGD:6480464 |
CTD |
| G |
Cd63 |
Cd63 molecule |
|
affects expression |
EXP |
7 |
2,208,659 |
2,211,323 |
RGD:6480464 |
CTD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
affects expression |
EXP |
18 |
56,756,511 |
56,765,711 |
RGD:6480464 |
CTD |
| G |
Cd79b |
Cd79b molecule, immunoglobulin-associated beta |
|
affects expression |
EXP |
10 |
95,703,129 |
95,706,275 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
affects expression |
EXP |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd81 |
Cd81 molecule |
|
affects expression |
EXP |
1 |
203,327,287 |
203,342,901 |
RGD:6480464 |
CTD |
| G |
Cd82 |
Cd82 molecule |
|
affects expression |
EXP |
3 |
77,831,771 |
77,875,764 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
affects expression |
EXP |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
affects expression |
EXP |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Cd8b |
CD8b molecule |
|
affects expression |
EXP |
4 |
104,536,454 |
104,552,683 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
affects expression |
EXP |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cd93 |
CD93 molecule |
|
affects expression |
EXP |
3 |
137,188,528 |
137,193,457 |
RGD:6480464 |
CTD |
| G |
Cd99l2 |
CD99 molecule-like 2 |
|
affects expression |
EXP |
15 |
5,673,664 |
5,719,158 |
RGD:6480464 |
CTD |
| G |
Cdc123 |
cell division cycle 123 |
|
affects expression |
EXP |
17 |
83,520,539 |
83,562,898 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
affects expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
affects expression |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc27 |
cell division cycle 27 |
|
increases expression |
EXP |
10 |
93,678,790 |
93,725,987 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
affects expression |
EXP |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
|
affects expression |
EXP |
13 |
95,640,342 |
95,865,501 |
RGD:6480464 |
CTD |
| G |
Cdc42bpb |
CDC42 binding protein kinase beta (DMPK-like) |
|
affects expression |
EXP |
6 |
136,053,885 |
136,136,234 |
RGD:6480464 |
CTD |
| G |
Cdc5l |
cell division cycle 5-like |
|
affects expression |
EXP |
9 |
11,165,631 |
11,204,135 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
affects expression |
EXP |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc7 |
cell division cycle 7 |
|
decreases expression |
EXP |
14 |
3,421,621 |
3,441,738 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh10 |
cadherin 10 |
|
affects expression |
EXP |
2 |
69,472,301 |
69,696,553 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
affects expression |
EXP |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
affects expression |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh14 |
cadherin 14 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdh17 |
cadherin 17 |
|
affects expression |
EXP |
5 |
26,047,222 |
26,099,173 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
affects expression |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdh22 |
cadherin 22 |
|
affects expression |
EXP |
3 |
156,155,004 |
156,275,540 |
RGD:6480464 |
CTD |
| G |
Cdh23 |
cadherin-related 23 |
|
affects expression |
EXP |
20 |
27,622,049 |
28,016,145 |
RGD:6480464 |
CTD |
| G |
Cdh3 |
cadherin 3 |
|
affects expression |
EXP |
19 |
36,343,823 |
36,393,819 |
RGD:6480464 |
CTD |
| G |
Cdh6 |
cadherin 6 |
|
affects expression |
EXP |
2 |
62,547,961 |
62,703,034 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
affects expression |
EXP |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdhr1 |
cadherin-related family member 1 |
|
affects expression |
EXP |
16 |
13,284,018 |
13,303,854 |
RGD:6480464 |
CTD |
| G |
Cdipt |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
affects expression |
EXP |
1 |
186,153,278 |
186,157,415 |
RGD:6480464 |
CTD |
| G |
Cdk12 |
cyclin-dependent kinase 12 |
|
affects expression |
EXP |
10 |
86,972,428 |
87,027,794 |
RGD:6480464 |
CTD |
| G |
Cdk16 |
cyclin-dependent kinase 16 |
|
affects expression |
EXP |
X |
12,910,972 |
12,916,939 |
RGD:6480464 |
CTD |
| G |
Cdk18 |
cyclin-dependent kinase 18 |
|
affects expression |
EXP |
13 |
44,996,447 |
45,004,813 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
affects expression |
EXP |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
affects expression |
EXP |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
increases cleavage |
EXP |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
affects response to substance |
EXP |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
affects expression |
EXP |
10 |
68,715,844 |
68,717,045 |
RGD:6480464 |
CTD |
| G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
|
affects expression |
EXP |
3 |
144,803,213 |
144,840,056 |
RGD:6480464 |
CTD |
| G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
|
affects expression |
EXP |
5 |
87,564,010 |
87,738,257 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
affects expression |
EXP |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
increases expression |
EXP |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk7 |
cyclin-dependent kinase 7 |
|
affects expression |
EXP |
2 |
31,500,629 |
31,525,590 |
RGD:6480464 |
CTD |
| G |
Cdk7 |
cyclin-dependent kinase 7 |
|
decreases expression |
EXP |
2 |
31,500,629 |
31,525,590 |
RGD:6480464 |
CTD |
| G |
Cdkl3 |
cyclin-dependent kinase-like 3 |
|
affects expression |
EXP |
10 |
37,527,865 |
37,552,851 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
decreases expression |
EXP |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects expression |
EXP |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
affects expression |
EXP |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
affects expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cdon |
cell adhesion associated, oncogene regulated |
|
affects expression |
EXP |
8 |
35,238,899 |
35,291,743 |
RGD:6480464 |
CTD |
| G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
affects expression |
EXP |
14 |
9,074,826 |
9,135,391 |
RGD:6480464 |
CTD |
| G |
Cds2 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 |
|
affects expression |
EXP |
3 |
120,025,455 |
120,063,992 |
RGD:6480464 |
CTD |
| G |
Cdx1 |
caudal type homeo box 1 |
|
affects expression |
EXP |
18 |
56,983,284 |
57,006,721 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
affects expression |
EXP |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
|
affects expression |
EXP |
1 |
80,070,252 |
80,076,528 |
RGD:6480464 |
CTD |
| G |
Ceacam11 |
carcinoembryonic antigen-related cell adhesion molecule 11 |
|
affects expression |
EXP |
1 |
77,808,746 |
77,814,982 |
RGD:6480464 |
CTD |
| G |
Ceacam3 |
carcinoembryonic antigen-related cell adhesion molecule 3 |
|
affects expression |
EXP |
1 |
77,529,236 |
77,541,770 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
affects expression |
EXP |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
affects expression |
EXP |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
affects expression |
EXP |
1 |
87,552,695 |
87,559,447 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
affects expression |
EXP |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Cela1 |
chymotrypsin-like elastase family, member 1 |
|
affects expression |
EXP |
7 |
139,439,589 |
139,452,717 |
RGD:6480464 |
CTD |
| G |
Cela2a |
chymotrypsin-like elastase family, member 2A |
|
affects expression |
EXP |
5 |
160,722,053 |
160,731,804 |
RGD:6480464 |
CTD |
| G |
Celf1 |
CUGBP, Elav-like family member 1 |
|
decreases expression |
EXP |
3 |
75,360,927 |
75,378,582 |
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
affects expression |
EXP |
17 |
82,708,354 |
83,025,139 |
RGD:6480464 |
CTD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
affects expression |
EXP |
7 |
123,900,366 |
124,036,122 |
RGD:6480464 |
CTD |
| G |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
affects expression |
EXP |
2 |
203,960,513 |
203,983,133 |
RGD:6480464 |
CTD |
| G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
|
affects expression |
EXP |
8 |
113,882,883 |
113,923,950 |
RGD:6480464 |
CTD |
| G |
Cenpi |
centromere protein I |
|
affects expression |
EXP |
X |
121,786,667 |
121,837,546 |
RGD:6480464 |
CTD |
| G |
Cep19 |
centrosomal protein 19 |
|
affects expression |
EXP |
11 |
70,500,062 |
70,508,772 |
RGD:6480464 |
CTD |
| G |
Cep350 |
centrosomal protein 350 |
|
affects expression |
EXP |
13 |
70,817,148 |
70,994,172 |
RGD:6480464 |
CTD |
| G |
Ces1e |
carboxylesterase 1E |
|
affects expression |
EXP |
19 |
14,887,900 |
14,924,363 |
RGD:6480464 |
CTD |
| G |
Ces2a |
carboxylesterase 2A |
|
affects expression |
EXP |
19 |
37,686 |
44,736 |
RGD:6480464 |
CTD |
| G |
Chrnd |
cholinergic receptor, nicotinic, delta (muscle) |
|
affects expression |
EXP |
9 |
85,996,421 |
86,004,839 |
RGD:6480464 |
CTD |
| G |
Chst15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
affects expression |
EXP |
1 |
191,708,603 |
191,737,958 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
affects expression |
EXP |
1 |
136,031,865 |
136,045,153 |
RGD:6480464 |
CTD |
| G |
Cirbp |
cold inducible RNA binding protein |
|
affects expression |
EXP |
7 |
11,047,003 |
11,050,820 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
affects expression |
EXP |
8 |
112,541,034 |
112,545,982 |
RGD:6480464 |
CTD |
| G |
Cit |
citron (rho-interacting, serine/threonine kinase 21) |
|
affects expression |
EXP |
12 |
41,858,134 |
42,019,601 |
RGD:6480464 |
CTD |
| G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
affects expression |
EXP |
X |
90,301,067 |
90,305,762 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
affects expression |
EXP |
5 |
141,258,564 |
141,259,455 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
affects expression |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
affects expression |
EXP |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
affects expression |
EXP |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2, sarcomeric |
|
affects expression |
EXP |
2 |
22,084,948 |
22,106,014 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
affects expression |
EXP |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clcc1 |
chloride channel CLIC-like 1 |
|
affects expression |
EXP |
2 |
204,245,357 |
204,278,530 |
RGD:6480464 |
CTD |
| G |
Clcn1 |
chloride channel, voltage-sensitive 1 |
|
affects expression |
EXP |
4 |
70,052,319 |
70,081,449 |
RGD:6480464 |
CTD |
| G |
Clcn2 |
chloride channel, voltage-sensitive 2 |
|
affects expression |
EXP |
11 |
82,427,792 |
82,441,293 |
RGD:6480464 |
CTD |
| G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
|
affects expression |
EXP |
16 |
32,447,259 |
32,518,533 |
RGD:6480464 |
CTD |
| G |
Clcn4 |
chloride channel, voltage-sensitive 4 |
|
affects expression |
EXP |
X |
44,355,648 |
44,419,524 |
RGD:6480464 |
CTD |
| G |
Clcn5 |
chloride channel, voltage-sensitive 5 |
|
affects expression |
EXP |
X |
27,383,769 |
27,409,877 |
RGD:6480464 |
CTD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
affects expression |
EXP |
10 |
14,379,803 |
14,403,898 |
RGD:6480464 |
CTD |
| G |
Clcnka |
chloride channel, voltage-sensitive Ka |
|
affects expression |
EXP |
5 |
160,274,377 |
160,290,369 |
RGD:6480464 |
CTD |
| G |
Clcnkb |
chloride channel, voltage-sensitive Kb |
|
affects expression |
EXP |
5 |
160,294,294 |
160,305,991 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
affects expression |
EXP |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn11 |
claudin 11 |
|
affects expression |
EXP |
2 |
116,626,427 |
116,639,732 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
affects expression |
EXP |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Clec4f |
C-type lectin domain family 4, member F |
|
affects expression |
EXP |
4 |
117,839,863 |
117,849,584 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 |
|
affects expression |
EXP |
5 |
154,005,244 |
154,066,883 |
RGD:6480464 |
CTD |
| G |
Clic5 |
chloride intracellular channel 5 |
|
affects expression |
EXP |
9 |
12,370,341 |
12,472,969 |
RGD:6480464 |
CTD |
| G |
Clic6 |
chloride intracellular channel 6 |
|
affects expression |
EXP |
11 |
32,516,492 |
32,559,195 |
RGD:6480464 |
CTD |
| G |
Clip2 |
CAP-GLY domain containing linker protein 2 |
|
affects expression |
EXP |
12 |
23,228,309 |
23,292,105 |
RGD:6480464 |
CTD |
| G |
Clk2 |
CDC-like kinase 2 |
|
affects expression |
EXP |
2 |
181,244,665 |
181,257,364 |
RGD:6480464 |
CTD |
| G |
Clk3 |
CDC-like kinase 3 |
|
affects expression |
EXP |
8 |
61,519,196 |
61,532,816 |
RGD:6480464 |
CTD |
| G |
Clmp |
CXADR-like membrane protein |
|
affects expression |
EXP |
8 |
43,661,696 |
43,769,479 |
RGD:6480464 |
CTD |
| G |
Clns1a |
chloride channel, nucleotide-sensitive, 1A |
|
affects expression |
EXP |
1 |
154,946,713 |
154,966,947 |
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
affects expression |
EXP |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clpb |
ClpB caseinolytic peptidase B homolog (E. coli) |
|
affects expression |
EXP |
1 |
159,126,512 |
159,246,279 |
RGD:6480464 |
CTD |
| G |
Clps |
colipase, pancreatic |
|
affects expression |
EXP |
20 |
6,802,428 |
6,804,608 |
RGD:6480464 |
CTD |
| G |
Clrn1 |
clarin 1 |
|
affects expression |
EXP |
2 |
148,193,633 |
148,243,575 |
RGD:6480464 |
CTD |
| G |
Clstn3 |
calsyntenin 3 |
|
affects expression |
EXP |
4 |
160,631,047 |
160,665,193 |
RGD:6480464 |
CTD |
| G |
Clta |
clathrin, light chain A |
|
affects expression |
EXP |
5 |
60,484,437 |
60,502,432 |
RGD:6480464 |
CTD |
| G |
Cltb |
clathrin, light chain B |
|
affects expression |
EXP |
17 |
16,063,715 |
16,081,277 |
RGD:6480464 |
CTD |
| G |
Cltc |
clathrin, heavy chain (Hc) |
|
affects expression |
EXP |
10 |
74,976,825 |
75,032,529 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
affects expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cma1 |
chymase 1, mast cell |
|
affects expression |
EXP |
15 |
34,083,202 |
34,084,387 |
RGD:6480464 |
CTD |
| G |
Cmklr1 |
chemokine-like receptor 1 |
|
affects expression |
EXP |
12 |
44,056,527 |
44,061,043 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
affects expression |
EXP |
4 |
120,059,311 |
120,065,996 |
RGD:6480464 |
CTD |
| G |
Cml3 |
camello-like 3 |
|
affects expression |
EXP |
4 |
119,964,411 |
119,966,307 |
RGD:6480464 |
CTD |
| G |
Cml5 |
camello-like 5 |
|
affects expression |
EXP |
4 |
119,981,266 |
120,006,794 |
RGD:6480464 |
CTD |
| G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
|
affects expression |
EXP |
4 |
122,033,037 |
122,041,891 |
RGD:6480464 |
CTD |
| G |
Cnga1 |
cyclic nucleotide gated channel alpha 1 |
|
affects expression |
EXP |
14 |
38,017,762 |
38,033,098 |
RGD:6480464 |
CTD |
| G |
Cnga2 |
cyclic nucleotide gated channel alpha 2 |
|
affects expression |
EXP |
X |
157,558,962 |
157,575,781 |
RGD:6480464 |
CTD |
| G |
Cnga3 |
cyclic nucleotide gated channel alpha 3 |
|
affects expression |
EXP |
9 |
36,180,295 |
36,203,098 |
RGD:6480464 |
CTD |
| G |
Cnga4 |
cyclic nucleotide gated channel alpha 4 |
|
affects expression |
EXP |
1 |
163,137,544 |
163,141,556 |
RGD:6480464 |
CTD |
| G |
Cngb1 |
cyclic nucleotide gated channel beta 1 |
|
affects expression |
EXP |
19 |
10,186,416 |
10,257,296 |
RGD:6480464 |
CTD |
| G |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
|
affects expression |
EXP |
X |
58,198,352 |
58,440,335 |
RGD:6480464 |
CTD |
| G |
Cnn1 |
calponin 1, basic, smooth muscle |
|
decreases expression |
EXP |
8 |
21,210,524 |
21,221,024 |
RGD:6480464 |
CTD |
| G |
Cnn3 |
calponin 3, acidic |
|
affects expression |
EXP |
2 |
218,044,803 |
218,075,914 |
RGD:6480464 |
CTD |
| G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
affects expression |
EXP |
10 |
89,519,421 |
89,525,978 |
RGD:6480464 |
CTD |
| G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
decreases expression |
EXP |
10 |
89,519,421 |
89,525,978 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects expression |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
|
affects expression |
EXP |
5 |
154,674,754 |
154,702,552 |
RGD:6480464 |
CTD |
| G |
Cntd1 |
cyclin N-terminal domain containing 1 |
|
affects expression |
EXP |
10 |
90,308,109 |
90,316,974 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
decreases expression |
EXP |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
decreases expression |
EXP |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Cntfr |
ciliary neurotrophic factor receptor |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cntn1 |
contactin 1 |
|
affects expression |
EXP |
7 |
130,658,836 |
130,845,071 |
RGD:6480464 |
CTD |
| G |
Cntn2 |
contactin 2 (axonal) |
|
affects expression |
EXP |
13 |
45,399,915 |
45,428,789 |
RGD:6480464 |
CTD |
| G |
Cntn3 |
contactin 3 (plasmacytoma associated) |
|
affects expression |
EXP |
4 |
137,121,006 |
137,421,081 |
RGD:6480464 |
CTD |
| G |
Cntn5 |
contactin 5 |
|
affects expression |
EXP |
8 |
6,530,878 |
7,190,594 |
RGD:6480464 |
CTD |
| G |
Cntn6 |
contactin 6 |
|
affects expression |
EXP |
4 |
140,078,007 |
140,450,348 |
RGD:6480464 |
CTD |
| G |
Cntnap1 |
contactin associated protein 1 |
|
affects expression |
EXP |
10 |
90,185,756 |
90,210,837 |
RGD:6480464 |
CTD |
| G |
Coil |
coilin |
|
affects expression |
EXP |
10 |
77,435,834 |
77,452,170 |
RGD:6480464 |
CTD |
| G |
Col10a1 |
collagen, type X, alpha 1 |
|
affects expression |
EXP |
20 |
38,725,164 |
38,731,513 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
affects expression |
EXP |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col12a1 |
collagen, type XII, alpha 1 |
|
affects expression |
EXP |
8 |
84,641,358 |
84,756,923 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
affects expression |
EXP |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col20a1 |
collagen, type XX, alpha 1 |
|
affects expression |
EXP |
3 |
170,105,596 |
170,136,828 |
RGD:6480464 |
CTD |
| G |
Col23a1 |
collagen, type XXIII, alpha 1 |
|
affects expression |
EXP |
10 |
36,808,661 |
37,096,560 |
RGD:6480464 |
CTD |
| G |
Col27a1 |
collagen, type XXVII, alpha 1 |
|
affects expression |
EXP |
5 |
80,198,078 |
80,316,354 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
affects expression |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
affects expression |
EXP |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
affects expression |
EXP |
16 |
82,899,206 |
83,045,102 |
RGD:6480464 |
CTD |
| G |
Col4a3 |
collagen, type IV, alpha 3 |
|
affects expression |
EXP |
9 |
81,910,656 |
82,036,998 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
affects expression |
EXP |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Colq |
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
|
affects expression |
EXP |
16 |
6,975,587 |
7,035,001 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
affects expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
affects expression |
EXP |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
affects expression |
EXP |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Crx |
cone-rod homeobox |
|
affects expression |
EXP |
1 |
76,190,656 |
76,196,333 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
affects expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryba2 |
crystallin, beta A2 |
|
affects expression |
EXP |
9 |
74,222,839 |
74,226,049 |
RGD:6480464 |
CTD |
| G |
Cryba4 |
crystallin, beta A4 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cryga |
crystallin, gamma A |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Crygb |
crystallin, gamma B |
|
affects expression |
EXP |
9 |
63,730,906 |
63,732,966 |
RGD:6480464 |
CTD |
| G |
Crygc |
crystallin, gamma C |
|
affects expression |
EXP |
9 |
63,720,585 |
63,722,620 |
RGD:6480464 |
CTD |
| G |
Crygd |
crystallin, gamma D |
|
affects expression |
EXP |
9 |
63,711,051 |
63,712,662 |
RGD:6480464 |
CTD |
| G |
Cryge |
crystallin, gamma E |
|
affects expression |
EXP |
9 |
63,698,609 |
63,701,230 |
RGD:6480464 |
CTD |
| G |
Crygf |
crystallin, gamma F |
|
affects expression |
EXP |
9 |
64,679,611 |
64,681,775 |
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
affects expression |
EXP |
15 |
36,320,075 |
36,440,579 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
affects expression |
EXP |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
affects expression |
EXP |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Csdc2 |
cold shock domain containing C2, RNA binding |
|
affects expression |
EXP |
7 |
120,290,137 |
120,323,640 |
RGD:6480464 |
CTD |
| G |
Csde1 |
cold shock domain containing E1, RNA binding |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
affects expression |
EXP |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
affects expression |
EXP |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
affects expression |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
affects expression |
EXP |
7 |
116,227,239 |
116,271,993 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
affects expression |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csk |
c-src tyrosine kinase |
|
affects expression |
EXP |
8 |
61,381,336 |
61,386,013 |
RGD:6480464 |
CTD |
| G |
Csn1s2a |
casein alpha s2-like A |
|
affects expression |
EXP |
14 |
21,805,291 |
21,819,354 |
RGD:6480464 |
CTD |
| G |
Csn1s2b |
casein alpha s2-like B |
|
affects expression |
EXP |
14 |
21,773,271 |
21,790,743 |
RGD:6480464 |
CTD |
| G |
Csn2 |
casein beta |
|
affects expression |
EXP |
14 |
21,847,981 |
21,855,216 |
RGD:6480464 |
CTD |
| G |
Csn3 |
casein kappa |
|
affects expression |
EXP |
14 |
21,674,805 |
21,681,360 |
RGD:6480464 |
CTD |
| G |
Csnk1a1 |
casein kinase 1, alpha 1 |
|
affects expression |
EXP |
18 |
57,541,673 |
57,564,560 |
RGD:6480464 |
CTD |
| G |
Csnk1d |
casein kinase 1, delta |
|
affects expression |
EXP |
10 |
110,166,244 |
110,197,233 |
RGD:6480464 |
CTD |
| G |
Csnk1e |
casein kinase 1, epsilon |
|
affects expression |
EXP |
7 |
117,402,718 |
117,420,764 |
RGD:6480464 |
CTD |
| G |
Csnk1g1 |
casein kinase 1, gamma 1 |
|
affects expression |
EXP |
8 |
70,193,231 |
70,301,592 |
RGD:6480464 |
CTD |
| G |
Csnk1g2 |
casein kinase 1, gamma 2 |
|
affects expression |
EXP |
7 |
10,587,247 |
10,620,696 |
RGD:6480464 |
CTD |
| G |
Csnk1g3 |
casein kinase 1, gamma 3 |
|
affects expression |
EXP |
18 |
49,369,579 |
49,451,893 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
affects expression |
EXP |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Csnk2b |
casein kinase 2, beta polypeptide |
|
affects expression |
EXP |
20 |
3,764,565 |
3,768,985 |
RGD:6480464 |
CTD |
| G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
affects expression |
EXP |
8 |
60,610,835 |
60,645,877 |
RGD:6480464 |
CTD |
| G |
Cspg5 |
chondroitin sulfate proteoglycan 5 (neuroglycan C) |
|
affects expression |
EXP |
8 |
114,621,534 |
114,635,336 |
RGD:6480464 |
CTD |
| G |
Csrp1 |
cysteine and glycine-rich protein 1 |
|
affects expression |
EXP |
13 |
48,750,202 |
48,775,815 |
RGD:6480464 |
CTD |
| G |
Csrp2 |
cysteine and glycine-rich protein 2 |
|
affects expression |
EXP |
7 |
49,910,235 |
49,929,536 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
affects expression |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Cst11 |
cystatin 11 |
|
affects expression |
EXP |
3 |
137,524,412 |
137,527,136 |
RGD:6480464 |
CTD |
| G |
Cst12 |
cystatin 12 |
|
affects expression |
EXP |
3 |
137,548,053 |
137,551,913 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
affects expression |
EXP |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
affects expression |
EXP |
1 |
207,991,313 |
207,993,021 |
RGD:6480464 |
CTD |
| G |
Cst8 |
cystatin 8 (cystatin-related epididymal specific) |
|
affects expression |
EXP |
3 |
137,557,637 |
137,564,274 |
RGD:6480464 |
CTD |
| G |
Csta |
cystatin A (stefin A) |
|
increases expression |
EXP |
11 |
66,456,248 |
66,467,253 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
affects expression |
EXP |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Ctbp1 |
C-terminal binding protein 1 |
|
affects expression |
EXP |
14 |
83,022,824 |
83,050,335 |
RGD:6480464 |
CTD |
| G |
Ctbp2 |
C-terminal binding protein 2 |
|
affects expression |
EXP |
1 |
192,463,615 |
192,492,935 |
RGD:6480464 |
CTD |
| G |
Ctbs |
chitobiase, di-N-acetyl- |
|
affects expression |
EXP |
2 |
244,648,365 |
244,662,878 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor (zinc finger protein) |
|
affects expression |
EXP |
19 |
35,461,942 |
35,514,934 |
RGD:6480464 |
CTD |
| G |
Ctf1 |
cardiotrophin 1 |
|
affects expression |
EXP |
1 |
187,001,445 |
187,006,655 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
affects expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
affects expression |
EXP |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Cthrc1 |
collagen triple helix repeat containing 1 |
|
affects expression |
EXP |
7 |
74,630,044 |
74,640,324 |
RGD:6480464 |
CTD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
affects expression |
EXP |
9 |
59,495,773 |
59,501,300 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
increases expression |
EXP |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
|
increases expression |
EXP |
3 |
67,809,603 |
67,860,287 |
RGD:6480464 |
CTD |
| G |
Ctnnd2 |
catenin (cadherin-associated protein), delta 2 |
|
affects expression |
EXP |
2 |
82,238,091 |
83,088,901 |
RGD:6480464 |
CTD |
| G |
Ctrb1 |
chymotrypsinogen B1 |
|
affects expression |
EXP |
19 |
41,611,382 |
41,616,058 |
RGD:6480464 |
CTD |
| G |
Ctrc |
chymotrypsin C (caldecrin) |
|
affects expression |
EXP |
5 |
160,742,491 |
160,755,332 |
RGD:6480464 |
CTD |
| G |
Ctrl |
chymotrypsin-like |
|
affects expression |
EXP |
19 |
35,774,031 |
35,775,881 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
affects expression |
EXP |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsc |
cathepsin C |
|
affects expression |
EXP |
1 |
144,629,802 |
144,661,183 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
EXP |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
affects expression |
EXP |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctse |
cathepsin E |
|
affects expression |
EXP |
13 |
44,582,911 |
44,605,241 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
affects expression |
EXP |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsj |
cathepsin J |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
affects expression |
EXP |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
affects expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsm |
cathepsin M |
|
affects expression |
EXP |
17 |
8,931,468 |
8,936,876 |
RGD:6480464 |
CTD |
| G |
Ctsq |
cathepsin Q |
|
affects expression |
EXP |
17 |
9,347,171 |
9,352,730 |
RGD:6480464 |
CTD |
| G |
Ctsr |
cathepsin R |
|
affects expression |
EXP |
17 |
9,235,486 |
9,244,251 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
affects expression |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cttn |
cortactin |
|
affects expression |
EXP |
1 |
204,865,768 |
204,901,221 |
RGD:6480464 |
CTD |
| G |
Cttnbp2 |
cortactin binding protein 2 |
|
affects expression |
EXP |
4 |
44,114,097 |
44,277,748 |
RGD:6480464 |
CTD |
| G |
Ctxn1 |
cortexin 1 |
|
affects expression |
EXP |
12 |
1,531,822 |
1,533,433 |
RGD:6480464 |
CTD |
| G |
Cubn |
cubilin (intrinsic factor-cobalamin receptor) |
|
affects expression |
EXP |
17 |
87,545,893 |
87,772,079 |
RGD:6480464 |
CTD |
| G |
Cul5 |
cullin 5 |
|
affects expression |
EXP |
8 |
57,080,787 |
57,132,486 |
RGD:6480464 |
CTD |
| G |
Cux1 |
cut-like homeobox 1 |
|
affects expression |
EXP |
12 |
21,223,919 |
21,516,938 |
RGD:6480464 |
CTD |
| G |
Cuzd1 |
CUB and zona pellucida-like domains 1 |
|
affects expression |
EXP |
1 |
190,887,527 |
190,900,654 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
affects expression |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
affects expression |
EXP |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
affects expression |
EXP |
11 |
17,193,505 |
17,241,549 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
affects expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
affects expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
affects expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
affects expression |
EXP |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
affects expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
affects expression |
EXP |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
affects expression |
EXP |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cyp4f37 |
cytochrome P450, family 4, subfamily f, polypeptide 37 |
|
affects expression |
EXP |
7 |
13,149,326 |
13,169,999 |
RGD:6480464 |
CTD |
| G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
|
affects expression |
EXP |
7 |
13,609,104 |
13,636,290 |
RGD:6480464 |
CTD |
| G |
Cyp4v3 |
cytochrome P450, family 4, subfamily v, polypeptide 3 |
|
affects expression |
EXP |
16 |
50,208,687 |
50,233,625 |
RGD:6480464 |
CTD |
| G |
Cyp4x1 |
cytochrome P450, family 4, subfamily x, polypeptide 1 |
|
affects expression |
EXP |
5 |
135,496,568 |
135,527,509 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
affects expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
affects expression |
EXP |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects expression |
EXP |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
affects expression |
EXP |
15 |
53,647,500 |
53,648,429 |
RGD:6480464 |
CTD |
| G |
Cyss |
cystatin S |
|
affects expression |
EXP |
3 |
138,826,625 |
138,830,963 |
RGD:6480464 |
CTD |
| G |
Cyth1 |
cytohesin 1 |
|
affects expression |
EXP |
10 |
108,189,311 |
108,253,419 |
RGD:6480464 |
CTD |
| G |
Cyth2 |
cytohesin 2 |
|
decreases expression |
EXP |
1 |
96,284,658 |
96,291,450 |
RGD:6480464 |
CTD |
| G |
Cyth3 |
cytohesin 3 |
|
decreases expression |
EXP |
12 |
11,169,420 |
11,198,144 |
RGD:6480464 |
CTD |
| G |
Dab2ip |
DAB2 interacting protein |
|
affects expression |
EXP |
3 |
14,667,700 |
14,840,625 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
affects expression |
EXP |
15 |
32,285,592 |
32,305,885 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
affects expression |
EXP |
8 |
113,470,871 |
113,483,433 |
RGD:6480464 |
CTD |
| G |
Dao |
D-amino-acid oxidase |
|
affects expression |
EXP |
12 |
43,627,593 |
43,648,332 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
affects expression |
EXP |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
affects expression |
EXP |
7 |
10,007,997 |
10,016,365 |
RGD:6480464 |
CTD |
| G |
Dars |
aspartyl-tRNA synthetase |
|
affects expression |
EXP |
13 |
41,077,395 |
41,132,513 |
RGD:6480464 |
CTD |
| G |
Daxx |
death-domain associated protein |
|
increases expression |
EXP |
20 |
5,121,854 |
5,127,601 |
RGD:6480464 |
CTD |
| G |
Daxx |
death-domain associated protein |
|
affects expression |
EXP |
20 |
5,121,854 |
5,127,601 |
RGD:6480464 |
CTD |
| G |
Dbc1 |
deleted in bladder cancer 1 |
|
affects expression |
EXP |
5 |
86,070,267 |
86,216,181 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
affects expression |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dbil5 |
diazepam binding inhibitor-like 5 |
|
affects expression |
EXP |
10 |
63,571,303 |
63,572,315 |
RGD:6480464 |
CTD |
| G |
Dbn1 |
drebrin 1 |
|
affects expression |
EXP |
17 |
15,194,687 |
15,208,660 |
RGD:6480464 |
CTD |
| G |
Dbnl |
drebrin-like |
|
affects expression |
EXP |
14 |
86,450,448 |
86,481,863 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site of albumin promoter (albumin D-box) binding protein |
|
affects expression |
EXP |
1 |
96,173,573 |
96,178,485 |
RGD:6480464 |
CTD |
| G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
affects expression |
EXP |
2 |
212,759,312 |
212,788,180 |
RGD:6480464 |
CTD |
| G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
|
affects expression |
EXP |
11 |
42,941,795 |
42,980,245 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
affects expression |
EXP |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dclk1 |
doublecortin-like kinase 1 |
|
affects expression |
EXP |
2 |
144,678,222 |
144,754,237 |
RGD:6480464 |
CTD |
| G |
Dclre1c |
DNA cross-link repair 1C |
|
affects expression |
EXP |
17 |
85,896,581 |
85,928,644 |
RGD:6480464 |
CTD |
| G |
Dcm5 |
Dcm5 protein |
|
affects expression |
EXP |
2 |
226,884,757 |
226,885,524 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
affects expression |
EXP |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Dcps |
decapping enzyme, scavenger |
|
affects expression |
EXP |
8 |
34,902,111 |
34,956,168 |
RGD:6480464 |
CTD |
| G |
Dctn1 |
dynactin 1 |
|
affects expression |
EXP |
4 |
117,390,323 |
117,410,119 |
RGD:6480464 |
CTD |
| G |
Dctn4 |
dynactin 4 (p62) |
|
affects expression |
EXP |
18 |
56,478,185 |
56,502,775 |
RGD:6480464 |
CTD |
| G |
Dctpp1 |
dCTP pyrophosphatase 1 |
|
affects expression |
EXP |
1 |
186,519,955 |
186,523,348 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
affects expression |
EXP |
X |
34,596,262 |
34,672,383 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
affects expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddb1 |
damage-specific DNA binding protein 1, 127kDa |
|
affects expression |
EXP |
1 |
213,095,187 |
213,120,986 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
decreases expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
affects expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
affects expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
affects expression |
EXP |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
affects expression |
EXP |
2 |
51,881,101 |
51,881,461 |
RGD:6480464 |
CTD |
| G |
Ddn |
dendrin |
|
affects expression |
EXP |
7 |
137,572,548 |
137,576,530 |
RGD:6480464 |
CTD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
affects expression |
EXP |
20 |
3,194,265 |
3,214,611 |
RGD:6480464 |
CTD |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
affects expression |
EXP |
13 |
85,801,449 |
85,846,636 |
RGD:6480464 |
CTD |
| G |
Ddt |
D-dopachrome tautomerase |
|
affects expression |
EXP |
20 |
13,591,785 |
13,594,256 |
RGD:6480464 |
CTD |
| G |
Ddx1 |
DEAD (Asp-Glu-Ala-Asp) box helicase 1 |
|
affects expression |
EXP |
6 |
36,794,602 |
36,825,473 |
RGD:6480464 |
CTD |
| G |
Ddx20 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
|
affects expression |
EXP |
2 |
200,929,985 |
200,937,976 |
RGD:6480464 |
CTD |
| G |
Ddx25 |
DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
|
affects expression |
EXP |
8 |
35,326,939 |
35,342,973 |
RGD:6480464 |
CTD |
| G |
Ddx39a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
affects expression |
EXP |
19 |
26,109,094 |
26,117,042 |
RGD:6480464 |
CTD |
| G |
Ddx39b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
|
affects expression |
EXP |
20 |
3,611,128 |
3,623,578 |
RGD:6480464 |
CTD |
| G |
Ddx46 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
|
affects expression |
EXP |
17 |
14,985,633 |
15,029,607 |
RGD:6480464 |
CTD |
| G |
Ddx5 |
DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
|
affects expression |
EXP |
10 |
96,131,888 |
96,139,423 |
RGD:6480464 |
CTD |
| G |
Ddx52 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
|
affects expression |
EXP |
10 |
72,222,689 |
72,245,419 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
affects expression |
EXP |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Decr2 |
2,4-dienoyl CoA reductase 2, peroxisomal |
|
affects expression |
EXP |
10 |
15,350,593 |
15,358,640 |
RGD:6480464 |
CTD |
| G |
Dedd |
death effector domain-containing |
|
affects expression |
EXP |
13 |
87,238,315 |
87,241,703 |
RGD:6480464 |
CTD |
| G |
Defa |
defensin, alpha 5, Paneth cell-specific |
|
affects expression |
EXP |
16 |
75,024,375 |
75,026,675 |
RGD:6480464 |
CTD |
| G |
Defb1 |
defensin beta 1 |
|
affects expression |
EXP |
16 |
74,980,054 |
74,995,445 |
RGD:6480464 |
CTD |
| G |
Defb22 |
defensin beta 22 |
|
affects expression |
EXP |
3 |
142,813,671 |
142,817,950 |
RGD:6480464 |
CTD |
| G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
|
affects expression |
EXP |
13 |
98,242,981 |
98,249,638 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
affects expression |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
decreases expression |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
affects expression |
EXP |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
affects expression |
EXP |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
affects expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
affects expression |
EXP |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dgka |
diacylglycerol kinase, alpha |
|
affects expression |
EXP |
7 |
2,018,858 |
2,045,336 |
RGD:6480464 |
CTD |
| G |
Dgkg |
diacylglycerol kinase, gamma |
|
affects expression |
EXP |
11 |
80,623,184 |
80,814,779 |
RGD:6480464 |
CTD |
| G |
Dgki |
diacylglycerol kinase, iota |
|
affects expression |
EXP |
4 |
64,207,192 |
64,663,627 |
RGD:6480464 |
CTD |
| G |
Dgkz |
diacylglycerol kinase zeta |
|
affects expression |
EXP |
3 |
76,312,721 |
76,342,603 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
affects expression |
EXP |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
affects expression |
EXP |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dhh |
desert hedgehog |
|
affects expression |
EXP |
7 |
137,666,984 |
137,672,479 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
affects expression |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhrs4 |
dehydrogenase/reductase (SDR family) member 4 |
|
affects expression |
EXP |
15 |
33,609,570 |
33,621,142 |
RGD:6480464 |
CTD |
| G |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
|
affects expression |
EXP |
3 |
51,521,343 |
51,543,552 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
increases expression |
EXP |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
affects expression |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine, type III |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
affects expression |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Dnah10 |
dynein, axonemal, heavy chain 10 |
|
affects expression |
EXP |
12 |
32,925,061 |
33,058,479 |
RGD:6480464 |
CTD |
| G |
Dpy30 |
dpy-30 homolog (C. elegans) |
|
affects expression |
EXP |
6 |
21,084,031 |
21,104,731 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
affects expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpys |
dihydropyrimidinase |
|
affects expression |
EXP |
7 |
75,368,238 |
75,446,160 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
affects expression |
EXP |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dpysl4 |
dihydropyrimidinase-like 4 |
|
affects expression |
EXP |
1 |
198,866,034 |
198,881,902 |
RGD:6480464 |
CTD |
| G |
Dpysl5 |
dihydropyrimidinase-like 5 |
|
affects expression |
EXP |
6 |
25,557,972 |
25,642,140 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
affects expression |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
affects expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
affects expression |
EXP |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
affects expression |
EXP |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Drd5 |
dopamine receptor D5 |
|
affects expression |
EXP |
14 |
77,768,060 |
77,769,487 |
RGD:6480464 |
CTD |
| G |
Drp2 |
dystrophin related protein 2 |
|
affects expression |
EXP |
X |
121,881,801 |
121,929,386 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
affects expression |
EXP |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Duox1 |
dual oxidase 1 |
|
affects expression |
EXP |
3 |
109,095,250 |
109,128,415 |
RGD:6480464 |
CTD |
| G |
Duox2 |
dual oxidase 2 |
|
affects expression |
EXP |
3 |
109,059,360 |
109,077,106 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
affects expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
decreases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp12 |
dual specificity phosphatase 12 |
|
affects expression |
EXP |
13 |
86,737,093 |
86,746,186 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
affects expression |
EXP |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
affects expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
affects expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
affects expression |
EXP |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
affects expression |
EXP |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Dvl1 |
dishevelled segment polarity protein 1 |
|
affects expression |
EXP |
5 |
172,705,951 |
172,717,626 |
RGD:6480464 |
CTD |
| G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
|
affects expression |
EXP |
4 |
30,496,410 |
30,809,622 |
RGD:6480464 |
CTD |
| G |
Dync1li1 |
dynein cytoplasmic 1 light intermediate chain 1 |
|
affects expression |
EXP |
8 |
119,103,884 |
119,137,411 |
RGD:6480464 |
CTD |
| G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
|
affects expression |
EXP |
19 |
469,163 |
510,647 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
affects expression |
EXP |
12 |
42,580,542 |
42,582,915 |
RGD:6480464 |
CTD |
| G |
Dynll2 |
dynein light chain LC8-type 2 |
|
affects expression |
EXP |
10 |
76,263,883 |
76,271,908 |
RGD:6480464 |
CTD |
| G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
|
affects expression |
EXP |
3 |
145,718,890 |
145,740,187 |
RGD:6480464 |
CTD |
| G |
Dynlt1 |
dynein light chain Tctex-type 1 |
|
affects expression |
EXP |
1 |
41,097,174 |
41,103,997 |
RGD:6480464 |
CTD |
| G |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
|
affects expression |
EXP |
11 |
34,879,733 |
34,970,998 |
RGD:6480464 |
CTD |
| G |
Dyt1 |
dystonia 1 |
|
affects expression |
EXP |
3 |
10,026,129 |
10,033,125 |
RGD:6480464 |
CTD |
| G |
Dzf17 |
zinc finger protein 17 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
EXP |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f5 |
E2F transcription factor 5 |
|
affects expression |
EXP |
2 |
88,346,236 |
88,361,733 |
RGD:6480464 |
CTD |
| G |
E2f6 |
E2F transcription factor 6 |
|
affects expression |
EXP |
6 |
40,494,286 |
40,534,152 |
RGD:6480464 |
CTD |
| G |
Eaf2 |
ELL associated factor 2 |
|
affects expression |
EXP |
11 |
65,763,410 |
65,809,967 |
RGD:6480464 |
CTD |
| G |
Ebf1 |
early B-cell factor 1 |
|
affects expression |
EXP |
10 |
29,770,047 |
30,163,200 |
RGD:6480464 |
CTD |
| G |
Ebp |
emopamil binding protein (sterol isomerase) |
|
affects expression |
EXP |
X |
26,331,199 |
26,337,542 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
affects expression |
EXP |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Ecel1 |
endothelin converting enzyme-like 1 |
|
affects expression |
EXP |
9 |
85,933,894 |
85,946,083 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
affects expression |
EXP |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
affects expression |
EXP |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
affects expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
affects expression |
EXP |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Eddm3b |
epididymal protein 3B |
|
affects expression |
EXP |
15 |
27,107,078 |
27,108,270 |
RGD:6480464 |
CTD |
| G |
Edg3l |
endothelial differentiation sphingolipid G-protein-coupled receptor 3-like |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
affects expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
affects expression |
EXP |
5 |
140,742,686 |
140,747,580 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
affects expression |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
affects expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
affects expression |
EXP |
3 |
170,295,327 |
170,304,505 |
RGD:6480464 |
CTD |
| G |
Eef1d |
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
|
affects expression |
EXP |
7 |
113,870,558 |
113,879,376 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
affects expression |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
affects expression |
EXP |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
EGF-containing fibulin-like extracellular matrix protein 1 |
|
affects expression |
EXP |
14 |
109,733,625 |
109,828,630 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
affects expression |
EXP |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Efna2 |
ephrin A2 |
|
affects expression |
EXP |
7 |
11,028,432 |
11,039,064 |
RGD:6480464 |
CTD |
| G |
Efna3 |
ephrin A3 |
|
affects expression |
EXP |
2 |
181,454,410 |
181,508,170 |
RGD:6480464 |
CTD |
| G |
Efnb1 |
ephrin B1 |
|
affects expression |
EXP |
X |
87,163,176 |
87,175,982 |
RGD:6480464 |
CTD |
| G |
Efs |
embryonal Fyn-associated substrate |
|
affects expression |
EXP |
15 |
33,018,805 |
33,028,147 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
affects expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like-domain, multiple 7 |
|
affects expression |
EXP |
3 |
4,760,574 |
4,769,909 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
affects expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
decreases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egln1 |
EGL nine homolog 1 (C. elegans) |
|
affects expression |
EXP |
19 |
55,080,670 |
55,118,226 |
RGD:6480464 |
CTD |
| G |
Egln2 |
EGL nine homolog 2 (C. elegans) |
|
affects expression |
EXP |
1 |
82,233,239 |
82,240,990 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
affects expression |
EXP |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
affects expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
affects expression |
EXP |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Egr3 |
early growth response 3 |
|
affects expression |
EXP |
15 |
50,477,453 |
50,479,909 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
affects expression |
EXP |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Ehd2 |
EH-domain containing 2 |
|
affects expression |
EXP |
1 |
76,292,179 |
76,310,584 |
RGD:6480464 |
CTD |
| G |
Ehd3 |
EH-domain containing 3 |
|
affects expression |
EXP |
6 |
21,638,705 |
21,686,023 |
RGD:6480464 |
CTD |
| G |
Ehd4 |
EH-domain containing 4 |
|
affects expression |
EXP |
3 |
106,594,931 |
106,658,722 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression |
EXP |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
affects expression |
EXP |
12 |
11,039,139 |
11,072,708 |
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
affects expression |
EXP |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif2b1 |
eukaryotic translation initiation factor 2B, subunit 1 alpha |
|
affects expression |
EXP |
12 |
33,138,323 |
33,146,596 |
RGD:6480464 |
CTD |
| G |
Eif2b2 |
eukaryotic translation initiation factor 2B, subunit 2 beta |
|
affects expression |
EXP |
6 |
109,266,354 |
109,272,778 |
RGD:6480464 |
CTD |
| G |
Eif2b3 |
eukaryotic translation initiation factor 2B, subunit 3 |
|
affects expression |
EXP |
5 |
137,323,754 |
137,398,327 |
RGD:6480464 |
CTD |
| G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
|
affects expression |
EXP |
6 |
25,159,823 |
25,165,561 |
RGD:6480464 |
CTD |
| G |
Eif2b5 |
eukaryotic translation initiation factor 2B, subunit 5 epsilon |
|
affects expression |
EXP |
11 |
82,634,006 |
82,643,992 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
affects expression |
EXP |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
|
affects expression |
EXP |
10 |
56,484,232 |
56,489,739 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
affects expression |
EXP |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif5b |
eukaryotic translation initiation factor 5B |
|
affects expression |
EXP |
9 |
36,937,415 |
36,993,650 |
RGD:6480464 |
CTD |
| G |
Epha5 |
EPH receptor A5 |
|
affects expression |
EXP |
14 |
25,524,170 |
25,896,798 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esrrb |
estrogen-related receptor beta |
|
affects expression |
EXP |
6 |
110,589,116 |
110,635,158 |
RGD:6480464 |
CTD |
| G |
Esyt1 |
extended synaptotagmin-like protein 1 |
|
affects expression |
EXP |
7 |
1,790,700 |
1,808,060 |
RGD:6480464 |
CTD |
| G |
Etf1 |
eukaryotic translation termination factor 1 |
|
increases expression |
EXP |
18 |
27,386,539 |
27,413,545 |
RGD:6480464 |
CTD |
| G |
Etfa |
electron-transfer-flavoprotein, alpha polypeptide |
|
affects expression |
EXP |
8 |
59,013,798 |
59,072,013 |
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
affects expression |
EXP |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
Exoc2 |
exocyst complex component 2 |
|
affects expression |
EXP |
17 |
39,951,129 |
40,125,385 |
RGD:6480464 |
CTD |
| G |
Exoc3 |
exocyst complex component 3 |
|
affects expression |
EXP |
1 |
29,897,536 |
29,928,281 |
RGD:6480464 |
CTD |
| G |
Exoc5 |
exocyst complex component 5 |
|
affects expression |
EXP |
15 |
25,008,521 |
25,053,098 |
RGD:6480464 |
CTD |
| G |
Exoc6 |
exocyst complex component 6 |
|
affects expression |
EXP |
1 |
241,964,047 |
242,008,416 |
RGD:6480464 |
CTD |
| G |
Exoc7 |
exocyst complex component 7 |
|
affects expression |
EXP |
10 |
106,400,889 |
106,419,793 |
RGD:6480464 |
CTD |
| G |
Exoc8 |
exocyst complex component 8 |
|
affects expression |
EXP |
19 |
55,066,272 |
55,068,761 |
RGD:6480464 |
CTD |
| G |
Extl3 |
exostosin-like glycosyltransferase 3 |
|
affects expression |
EXP |
15 |
44,400,139 |
44,424,584 |
RGD:6480464 |
CTD |
| G |
Eya2 |
eyes absent homolog 2 (Drosophila) |
|
affects expression |
EXP |
3 |
156,731,490 |
156,848,691 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
affects expression |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
decreases expression |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
affects expression |
EXP |
16 |
81,327,237 |
81,346,544 |
RGD:6480464 |
CTD |
| G |
F11r |
F11 receptor |
|
affects expression |
EXP |
13 |
87,369,918 |
87,393,508 |
RGD:6480464 |
CTD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
affects expression |
EXP |
17 |
34,093,525 |
34,270,498 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
affects expression |
EXP |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
affects expression |
EXP |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
affects expression |
EXP |
2 |
25,886,177 |
25,899,128 |
RGD:6480464 |
CTD |
| G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
|
affects expression |
EXP |
2 |
26,073,852 |
26,078,618 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
affects expression |
EXP |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
affects expression |
EXP |
16 |
81,348,678 |
81,358,991 |
RGD:6480464 |
CTD |
| G |
F9 |
coagulation factor IX |
|
affects expression |
EXP |
X |
145,527,978 |
145,575,966 |
RGD:6480464 |
CTD |
| G |
Fndc5 |
fibronectin type III domain containing 5 |
|
affects expression |
EXP |
5 |
148,296,328 |
148,304,372 |
RGD:6480464 |
CTD |
| G |
Foxc2 |
forkhead box C2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
affects expression |
EXP |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gzmb |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
affects expression |
EXP |
15 |
35,195,075 |
35,198,506 |
RGD:6480464 |
CTD |
| G |
Gzmbl2 |
Granzyme B-like 2 |
|
affects expression |
EXP |
15 |
35,061,676 |
35,074,048 |
RGD:6480464 |
CTD |
| G |
Hdac5 |
histone deacetylase 5 |
|
affects expression |
EXP |
10 |
91,266,512 |
91,277,705 |
RGD:6480464 |
CTD |
| G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
|
affects expression |
EXP |
8 |
127,076,654 |
127,085,885 |
RGD:6480464 |
CTD |
| G |
Hist1h2bh |
histone cluster 1, H2bh |
|
affects expression |
EXP |
17 |
50,111,215 |
50,111,595 |
RGD:6480464 |
CTD |
| G |
Hist1h2bl |
histone cluster 1, H2bl |
|
affects expression |
EXP |
17 |
50,343,037 |
50,343,698 |
RGD:6480464 |
CTD |
| G |
Hmg1l1 |
high-mobility group (nonhistone chromosomal) protein 1-like 1 |
|
affects expression |
EXP |
19 |
56,978,498 |
56,979,758 |
RGD:6480464 |
CTD |
| G |
Hoxa9 |
homeobox A9 |
|
affects expression |
EXP |
4 |
80,524,246 |
80,526,491 |
RGD:6480464 |
CTD |
| G |
Il12rb1 |
interleukin 12 receptor, beta 1 |
|
affects expression |
EXP |
16 |
19,126,653 |
19,137,584 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
affects expression |
EXP |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
|
affects expression |
EXP |
1 |
37,635,767 |
37,711,074 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
affects expression |
EXP |
20 |
5,150,810 |
5,169,264 |
RGD:6480464 |
CTD |
| G |
Klk1 |
kallikrein 1 |
|
affects expression |
EXP |
1 |
94,624,828 |
94,628,822 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
affects expression |
EXP |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
affects expression |
EXP |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
increases expression |
EXP |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
LOC100360950 |
GF20391-like |
|
affects expression |
EXP |
17 |
50,386,764 |
50,411,138 |
RGD:6480464 |
CTD |
| G |
LOC100362916 |
rCG61219-like |
|
affects expression |
EXP |
15 |
27,148,357 |
27,151,016 |
RGD:6480464 |
CTD |
| G |
LOC686736 |
similar to H3 histone, family 3B |
|
affects expression |
EXP |
1 |
212,798,225 |
212,798,635 |
RGD:6480464 |
CTD |
| G |
Lrp3 |
low density lipoprotein receptor-related protein 3 |
|
affects expression |
EXP |
1 |
87,711,390 |
87,725,636 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
affects expression |
EXP |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Micalcl |
MICAL C-terminal like |
|
affects expression |
EXP |
1 |
170,176,936 |
170,215,812 |
RGD:6480464 |
CTD |
| G |
Micu2 |
mitochondrial calcium uptake 2 |
|
affects expression |
EXP |
15 |
36,961,910 |
37,048,305 |
RGD:6480464 |
CTD |
| G |
Mpc1 |
mitochondrial pyruvate carrier 1 |
|
affects expression |
EXP |
1 |
47,077,723 |
47,089,344 |
RGD:6480464 |
CTD |
| G |
Mrgprx1 |
MAS-related GPR, member X1 |
|
affects expression |
EXP |
1 |
98,479,104 |
98,480,042 |
RGD:6480464 |
CTD |
| G |
Mrgprx3 |
MAS-related GPR, member X3 |
|
affects expression |
EXP |
1 |
97,729,771 |
97,757,150 |
RGD:6480464 |
CTD |
| G |
Myh1 |
myosin, heavy chain 1, skeletal muscle, adult |
|
affects expression |
EXP |
10 |
53,894,388 |
53,917,948 |
RGD:6480464 |
CTD |
| G |
Nav2 |
neuron navigator 2 |
|
affects expression |
EXP |
1 |
99,041,044 |
99,410,077 |
RGD:6480464 |
CTD |
| G |
Ndufa11 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ndufa7l |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7-like |
|
affects expression |
EXP |
3 |
55,312,099 |
55,312,440 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
affects expression |
EXP |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Npc1 |
Niemann-Pick disease, type C1 |
|
affects expression |
EXP |
18 |
3,725,415 |
3,777,707 |
RGD:6480464 |
CTD |
| G |
Obp2b |
odorant binding protein 2B |
|
affects expression |
EXP |
3 |
3,934,278 |
3,937,462 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
affects expression |
EXP |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Pcdha10 |
protocadherin alpha 10 |
|
affects expression |
EXP |
18 |
29,721,603 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pcdha12 |
protocadherin alpha 12 |
|
affects expression |
EXP |
18 |
29,734,513 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pcdha9 |
protocadherin alpha 9 |
|
affects expression |
EXP |
18 |
29,715,235 |
29,928,031 |
RGD:6480464 |
CTD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
affects expression |
EXP |
20 |
10,541,656 |
10,563,199 |
RGD:6480464 |
CTD |
| G |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
|
affects expression |
EXP |
7 |
116,880,751 |
116,886,199 |
RGD:6480464 |
CTD |
| G |
Plekha5 |
pleckstrin homology domain containing, family A member 5 |
|
affects expression |
EXP |
4 |
177,616,038 |
177,784,751 |
RGD:6480464 |
CTD |
| G |
Ppfia3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
|
affects expression |
EXP |
1 |
95,808,898 |
95,837,739 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
affects expression |
EXP |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
decreases expression |
EXP |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
affects expression |
EXP |
1 |
17,328,563 |
17,752,200 |
RGD:6480464 |
CTD |
| G |
Rab1b |
RAB1B, member RAS oncogene family |
|
affects expression |
EXP |
1 |
207,720,833 |
207,727,458 |
RGD:6480464 |
CTD |
| G |
Rab5al1 |
Rab5a, member RAS oncogene family-like 1 |
|
affects expression |
EXP |
14 |
73,512,120 |
73,515,650 |
RGD:6480464 |
CTD |
| G |
Rab8a |
RAB8A, member RAS oncogene family |
|
affects expression |
EXP |
16 |
18,078,519 |
18,099,882 |
RGD:6480464 |
CTD |
| G |
Rbm14 |
RNA binding motif protein 14 |
|
affects expression |
EXP |
1 |
207,410,484 |
207,421,760 |
RGD:6480464 |
CTD |
| G |
Reg3a |
regenerating islet-derived 3 alpha |
|
affects expression |
EXP |
4 |
112,366,001 |
112,368,767 |
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
affects expression |
EXP |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
Rnf39 |
ring finger protein 39 |
|
affects expression |
EXP |
20 |
1,697,530 |
1,703,019 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
affects expression |
EXP |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rpl7a |
ribosomal protein L7a |
|
affects expression |
EXP |
18 |
5,807,901 |
5,810,543 |
RGD:6480464 |
CTD |
| G |
Rps10l1 |
ribosomal protein S10-like 1 |
|
affects expression |
EXP |
6 |
74,838,974 |
74,839,471 |
RGD:6480464 |
CTD |
| G |
Rps2 |
ribosomal protein S2 |
|
affects expression |
EXP |
10 |
13,975,350 |
13,977,199 |
RGD:6480464 |
CTD |
| G |
Rps27l2 |
ribosomal protein S27-like 2 |
|
affects expression |
EXP |
12 |
29,143,461 |
29,143,842 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
affects expression |
EXP |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Serpina4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression |
EXP |
6 |
128,133,692 |
128,142,768 |
RGD:6480464 |
CTD |
| G |
Slc16a10 |
solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
affects expression |
EXP |
20 |
44,211,651 |
44,325,332 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression |
EXP |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Spag4 |
sperm associated antigen 4 |
|
affects expression |
EXP |
3 |
146,472,609 |
146,476,953 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
affects expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Tgoln2 |
trans-golgi network protein 2 |
|
affects expression |
EXP |
4 |
106,110,153 |
106,117,906 |
RGD:6480464 |
CTD |
| G |
Timm8a1 |
translocase of inner mitochondrial membrane 8 homolog a1 (yeast) |
|
affects expression |
EXP |
X |
121,993,810 |
121,997,685 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
affects expression |
EXP |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
affects expression |
EXP |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ush2a |
Usher syndrome 2A (autosomal recessive, mild) |
|
affects expression |
EXP |
13 |
104,481,807 |
104,606,485 |
RGD:6480464 |
CTD |
| G |
Wfdc18 |
WAP four-disulfide core domain 18 |
|
affects expression |
EXP |
10 |
71,930,940 |
71,933,083 |
RGD:6480464 |
CTD |
| G |
Ybx3 |
Y box binding protein 3 |
|
affects expression |
EXP |
4 |
169,076,517 |
169,099,849 |
RGD:6480464 |
CTD |
Term paths to the root
|